Dr. Tolulope Adewole

Managing Director & Chief Executive Officer

Dr. Adewole is the Managing Director and Chief Executive Officer of NSIA Advanced Medical Services Limited (MedServe). He is a highly regarded healthcare expert with over two decades of diverse experience, spanning clinical practice, healthcare management, and executive leadership. His academic journey began at the University of Ibadan, followed by a medical internship at Lagos University Teaching Hospital and a Residency Program in Chemical Pathology at the University College Hospital, Ibadan, where he earned a Fellowship from the National Postgraduate Medical College of Nigeria. In addition to his medical training, he completed a Healthcare Management certificate program at the University of Washington. He is also a distinguished member of several professional organizations, including the American Diagnostic and Laboratory Medicine (ADLM) and the American Association of Clinical Oncologists (ASCO). 

In 2019, Dr. Adewole was appointed CEO of NSIA Healthcare Development & Investment Company (NHDIC), where he oversaw healthcare projects valued at $21 million, primarily focused on cancer care and diagnostics across Nigeria. Following his appointment as the CEO MedServe, he is leading the Healthcare Expansion Programme, an ambitious initiative involving the development and operationalisation of 23 modern medical diagnostic centres, 3 oncology centres, and 7 catheterization laboratories, with a projected cost of approximately $280 million. 

He also contributes to the healthcare industry in Nigeria through his role on the Finance Committee of the Healthcare Federation of Nigeria and as a board member for the Covenant University World Bank Project and the Bloomberg New Economy International Coalition Against Cancer. 

In 2025, Dr. Adewole was nominated as a Member of the National Technical Working Group on Nuclear Medicine in Nigeria, an advisory body established by the Federal Ministry of Health and Social Welfare to guide the implementation and expansion of nuclear medicine services across the country. Recognised for his expertise in healthcare financing, strategy, and quality improvement, his contributions have been acknowledged by prestigious organizations such as the Institute of Directors, the Society for Quality in Healthcare, and Cure4Cancer. With a strong track record of leadership in healthcare transformation, Dr. Adewole continues to drive impactful projects that enhance access to high-quality medical services in Nigeria and beyond.